Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"

Document Type: Article

Version: Accepted version

Date: 2021

• Description
• View document

Name: Mercader_cd_argu.pdf

Size: 146.5Kb

Format: PDF

View/Open

Citation: Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Sanz-Sanchez T, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Borrego L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". Contact Dermatitis. 2021;85(5):611-3. DOI: 10.1111/cod.13941

Permanent link: http://hdl.handle.net/10230/52245

Author: Mercader García, Pedro ; Pastor-Nieto, María ; González-Pérez, Ricardo ; Giménez Arnau, Anna Maria ; Ruiz-Gonzalez, Inmaculada ; Mora-Fernández, Verónica ; Miquel, Javier ; Silvestre Salvador, Juan Francisco ; Sanz-Sánchez, Tatiana ; Perez-Feal, Patricia ; Sánchez-Pérez, Javier ; Heras-Mendaza, Felipe ; Serra-Baldrich, Esther ; Hervella Garcés, Marcos ; Gatica-Ortega, María-Elena ; García-Doval, Ignacio ; Borrego, Leopoldo

DOI: http://dx.doi.org/10.1111/cod.13941

Show full item record

This item appears in the following Collection(s)

• Articles (Hospital del Mar Research Institute): 5233